Pharmaceuticals and Biotech | Media Room

Press Release May 9, 2022

Wellgistics LLC Announces Acquisition of American Pharmaceutical Ingredients LLC, Dba American Pharmaceutical Distributors (APD)

Wellgistics' Founder Brian Norton today announced the acquisition of Detroit-based Manufacturing and Distribution companies API and APD. Read More

Press Release Apr 26, 2022

Concentric Health Experience Named Agency of the Year at the 2022 Manny Awards

Press Release Apr 25, 2022

Microbiologics Acquires Cryologics

Press Release Apr 25, 2022

Pano Therapeutics, Inc. Announces the Strategic Acquisition of NovaTarg Therapeutics, Inc. and the Appointment of Ken Batchelor, PhD, as Head of Research & Development

Press Release Apr 22, 2022

SERUM X - a New, Innovative Form of Topical Pain Relief With Powerful Super-Antioxidant Action From New Biotech AO Biologix

"SERUM X is the ultimate game changer for those with nagging pain. I can't wait for the world to try it," says co-creator Dan Purser MD. Read More

Press Release Apr 20, 2022

InvestChile Promotes Pharmaceutical Companies Landing in South America's Business Hub

The agency has published an e-book with a step-by-step operating guide that details the benefits for international companies of setting up in the Southern Cone country. Read More

Press Release Apr 19, 2022

Scailyte's 5th Anniversary Mini-Symposium - Machine Learning Meets Multi-Omics for Precision Medicine

Bringing industry and academia together to discuss the potential impact of single-cell analytics powered by machine learning for precision medicine. Read More

Press Release Apr 12, 2022

The Story Behind Sambrosa's Perfectly Blended Allergy Nighttime Syrup

Before Sambrosa's perfectionated sleep syrup was a bestselling product, it was the work of a homeopathic doctor committed to helping her patients get higher-quality rest Read More

Press Release Apr 11, 2022

Scailyte AG Announces a Partnership With Sirona DX for AI-Driven End-Point Specific Single-Cell Analysis

Press Release Apr 11, 2022

Cellvera Supports Oxford University and the UK Department of Health and Social Care With Expansion of the PRINCIPLE Trial

PRINCIPLE has been the UK Government's national priority platform trial of COVID-19 treatments, and one of the world's largest currently taking place in an outpatient setting Read More

Press Release Apr 8, 2022

Consortium of Japanese Energy Companies Acquire 50 MW Tahara Biomass Project From Solariant Capital

Press Release Apr 5, 2022

EZEN Partners With ComplianceQuest to Support Clients' Digital Transformation

Press Release Apr 4, 2022

Clinical Outcomes Solutions and FingerPost Mark Five Years of Collaboration Dedicated to Informing the COA Competitive Landscape in the Anti-Cancer Therapy Space

Press Release Mar 30, 2022

LTO Network Becomes the World's Premier Blockchain Network for eClinical Applications Through the Partnership of Triall With Crucial Data Solutions

LTO Network announces that through its collaboration with integrator Sphereon, it will host the world's next generation of eClinical data. Triall will integrate its blockchain APIs with the eClinical solutions of CDS, realizing the world's first end-to-end eClinical platform powered by blockchain. Read More

Press Release Mar 29, 2022

Ebvia Announces Positive Results Published in Nature for TMPRSS2 Inhibitor for the Prevention and Treatment of COVID-19

A Novel, Simple-to-Use, Outpatient Nasal Spray for COVID-19 and Influenza in Development Read More

Press Release Mar 29, 2022

Longwood Fund Announces Longwood Healthcare Leaders, a Web Conference for Industry Leaders, on May 4-5, 2022

Press Release Mar 21, 2022

Tadgh Prendeville to Assume the Role of President and CEO at Regis Technologies, Inc.

Press Release Mar 21, 2022

Vivacitas Oncology Appoints Harvard Professor of Medicine Dr. David Reardon, MD to the Company's Neuro-Oncology Medical Advisory Board

Press Release Mar 15, 2022

Philogen SpA - Notice of Full Year 2021 Results

Press Release Mar 14, 2022

Almac Pharma Services Expands Its Unique Ultra-Low Temperature Solutions for Advanced Therapy Medicinal Products

Tailored service enables processing and QP release within 20 hours Read More

Press Release Mar 11, 2022

Evidence of Manipulated Lyme Disease Diagnostics Presented to Suffolk County, NY Health Commissioner

Nonprofit Group Seeks Remedy for Decades of Inaccurate Lyme Disease Testing Read More

Press Release Mar 7, 2022

Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory Board

Press Release Mar 4, 2022

CDMOs Recognized for Service and Leadership

Pharma and biotech customers select service providers for excellence in capabilities, expertise, quality, compatibility, reliability, and service Read More

Press Release Mar 3, 2022

OliLux Biosciences Kickstarts a Partnership With the UCSF Center for Tuberculosis and the Rapid Research in Diagnostics Development (R2D2) for TB Network

OliLux Biosciences is partnering with the R2D2 TB Network and the UCSF Center for Tuberculosis to clinically evaluate and advance its novel rapid detection technology for drug-resistant tuberculosis. Read More

Press Release Mar 2, 2022

Sensus Healthcare Sells Its Sculptura™ Assets to Empyrean Medical Systems for $15 Million in Cash

Sale permits Sensus to focus on the core dermatology market while providing capital for channel expansion Read More

Press Release Feb 28, 2022

Ferrer Announces Distribution Agreement With United Therapeutics for Treprostinil Inhalation Solution for Pulmonary Hypertension Associated With Interstitial Lung Disease

PH-ILD is a rare, serious, and progressive illness without an approved treatment in Europe and many other parts of the world Read More

Press Release Feb 23, 2022

Scailyte Hosts Webinar About Supervised Learning of Disease-Associated Cell States and Dynamics

Webinar on the latest developments in the analysis of single-cell data, including from transcriptomic and imaging technologies. Read More

Press Release Feb 21, 2022

Stanislaus County to Conduct First-Ever Online Tax Sale on Bid4Assets

The online auction will open March 7 with 40 properties listed. Read More

Press Release Feb 17, 2022

Bob Discordia Joins CaaMTech as Chief Scientific Officer

Dr. Discordia brings over 30 years of pharmaceutical industry experience to CaaMTech Read More

Press Release Feb 17, 2022

Philogen Receives Authorisation to Initiate New Study in France to Evaluate Nidlegy™ in Several Non-Melanoma Skin Cancers

Press Release Feb 16, 2022

K3-Innovations Has Retained Biopharmaceutical Development Veteran Jim Baker to Drive Expansion of Its Clinical Research Offerings

Press Release Feb 14, 2022

Vivacitas Oncology to Present at the 2022 BIO CEO & Investor Conference

Press Release Feb 7, 2022

Nemysis Ltd Announces Appointment of Antonino Santoro as Adviser for Scientific Affairs

Press Release Feb 3, 2022

Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor

Press Release Feb 1, 2022

Gb Sciences and Michigan State University Researchers Have Identified the Complicated Truth Behind the Opportunity for an Effective Cannabinoid-Based Coronavirus Treatment

Gb Sciences' collaboration with MSU has received media coverage across the country, starting with an interview from WLNS-TV in Lansing, Michigan, and interviews with Gb Sciences in the magazines 'Cannabis Business Times' and 'Hemp Grower' Read More

Press Release Jan 31, 2022

Vivacitas Oncology Strengthens Its Neuro-Oncology Board With World-Class Advisor Dr. Katherine Peters, MD, PhD, FAAN

Press Release Jan 25, 2022

Premier Pharmacy Services Adds KRYSTEXXA® (Pegloticase) to Rare Disease Portfolio

Press Release Jan 24, 2022

Explora BioLabs Launches Preclinical Vivarium Model in Seattle

Turnkey research facilities expand national network, opens new market Read More

Press Release Jan 24, 2022

Atrial Fibrilillation Study by NativeCardio and the Texas Heart Institute Show Ultra-Low Cardioversion is Possible

Press Release Jan 24, 2022

Cellvera Receives $20M Purchase Order for COVID-19 Oral Antiviral Avigan®

Press Release Jan 21, 2022

AiPharma Announces Corporate Rebrand, Changing Its Name to Cellvera

Cellvera unveils new logo and corporate identity as part of the extensive rebranding initiative Read More

Press Release Jan 18, 2022

Vivacitas Oncology to Present a Poster on AR-67 at the 3rd Annual Glioblastoma Drug Development Summit

Press Release Jan 17, 2022

Dr. Erkut Borazanci, MD, Joins Vivacitas Oncology's Pancreatic Medical Advisory Board

Press Release Jan 12, 2022

Craig Darling Joins Virgo Surgical Video Solutions

Twenty-Year Life Sciences Commercial Leader joins Virgo to Scale Clinical Trial Acceleration Platform Read More

Press Release Jan 11, 2022

FDA Pre-Submission Filed for Cardio inCode-SCORE

Commencement of regulatory pathway for U.S. market approval Read More

Press Release Jan 10, 2022

Vivacitas Oncology to Present AR-67 at the Biotech Showcase Investor Conference

Press Release Jan 10, 2022

Shauna Aherne Appointed New President of MedEvoke

Press Release Jan 10, 2022

Halo Biosciences Participating in BIO @ JPM and BIOTECH SHOWCASE™ During J.P. Morgan Week 2022

Press Release Jan 10, 2022

Scailyte Closes Financing Round and Onboards Top Biotech Leaders to Prepare for Growth in 2022

First closing of Series A round and onboarding of top biotech leaders to fuel growth in 2022 Read More

Press Release Jan 7, 2022

Enalare Files Additional Patent Application for Lead Compound ENA-001 - Enhancing Potential Global Exclusivity Through 2042

Press Release Jan 3, 2022

Vivacitas Oncology Welcomes Dr. Jai Grewal, MD, and Expands Its Neuro-Oncology Advisory Board

Press Release Dec 28, 2021

Enalare Therapeutics Invited to Present at Upcoming Biotech Conferences

H.C. Wainwright Bioconnect Conference - Jan. 10, 2022; Biotech Showcase 2022 Conference - Jan. 10, 2022 Read More

Press Release Dec 22, 2021

Qualer Has Added New Automation Software Features for Their Asset Maintenance Software Solutions

Press Release Dec 15, 2021

Hyris Fully Embraces the Immunology Sector to Better Fight COVID-19 and Beyond, Presenting Its New, Disruptive T-Cell Test to the International Conference 'A-Wish'

Hyris is going to present its new test to detect the body's T Cell immune response to SARS-CoV-2 on 17 December 2021, at "A-WISH", Alicante-Winter Immunology Symposium in Health, which will address strategies for the COVID-19 response and the development of the vaccines against SARS-CoV-2. This new solution leverages the Hyris System™, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform. Read More

Press Release Dec 14, 2021

Enalare Therapeutics Receives Rare Pediatric Disease Designation for Lead Compound ENA-001 for the Treatment of Apnea of Prematurity

Press Release Dec 13, 2021

Courier Health Named One of the Most Innovative Startups of 2021 by PM360

Press Release Nov 30, 2021

Vivacitas Oncology Announces Additions to Leadership Team and Board

Press Release Nov 30, 2021

Enalare Therapeutics Files New Patent Application for Lead Product ENA-001 - Potentially Extending Global Exclusivity Through 2042

Press Release Nov 22, 2021

Vivacitas Oncology, Inc. to Present on AR-67 at the Annual 5th Meridian Clinical Trials Conference

Press Release Nov 16, 2021

CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction

Scientists will assess the potential of psychedelic compounds for treating addiction Read More